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Thalamic deep brain stimulation is a mainstay treatment for severe and drug-refractory essential tremor, but postoperative man-
agement may be complicated in some patients by a progressive cerebellar syndrome including gait ataxia, dysmetria, worsening of
intention tremor and dysarthria. Typically, this syndrome manifests several months after an initially effective therapy and neces-
sitates frequent adjustments in stimulation parameters. There is an ongoing debate as to whether progressive ataxia reflects a
delayed therapeutic failure due to disease progression or an adverse effect related to repeated increases of stimulation intensity. In
this study we used a multimodal approach comparing clinical stimulation responses, modelling of volume of tissue activated and
metabolic brain maps in essential tremor patients with and without progressive ataxia to disentangle a disease-related from a
stimulation-induced aetiology. Ten subjects with stable and effective bilateral thalamic stimulation were stratified according to the
presence (five subjects) of severe chronic-progressive gait ataxia. We quantified stimulated brain areas and identified the stimula-
tion-induced brain metabolic changes by multiple 18F-fluorodeoxyglucose positron emission tomography performed with and
without active neurostimulation. Three days after deactivating thalamic stimulation and following an initial rebound of symptom
severity, gait ataxia had dramatically improved in all affected patients, while tremor had worsened to the presurgical severity, thus
indicating a stimulation rather than disease-related phenomenon. Models of the volume of tissue activated revealed a more
ventrocaudal stimulation in the (sub)thalamic area of patients with progressive gait ataxia. Metabolic maps of both patient
groups differed by an increased glucose uptake in the cerebellar nodule of patients with gait ataxia. Our data suggest that chronic
progressive gait ataxia in essential tremor is a reversible cerebellar syndrome caused by a maladaptive response to neurostimulation
of the (sub)thalamic area. The metabolic signature of progressive gait ataxia is an activation of the cerebellar nodule, which may be
caused by inadvertent current spread and antidromic stimulation of a cerebellar outflow pathway originating in the vermis. An
anatomical candidate could be the ascending limb of the uncinate tract in the subthalamic area. Adjustments in programming and
precise placement of the electrode may prevent this adverse effect and help fine-tuning deep brain stimulation to ameliorate tremor
without negative cerebellar signs.
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Introduction
Motor disability in essential tremor results predominantly
from the complex interaction of postural-, action- and in-
tention-tremor with goal-directed hand movements, but
10–15% of patients additionally present mild cerebellar
symptoms, such as saccadic abnormalities (Helmchen et al.,
2003), dysmetria or impaired tandem gait (Flament and
Hore, 1986; Hallett et al., 1991; Fasano et al., 2010).
There is an ongoing debate on whether a cerebellar dys-
function in essential tremor is caused by disease progression
and neurodegeneration (Louis et al., 2007) or a functional
disruption of the cerebello-thalamo-cortical network
through the interference of tremor-related neuronal oscilla-
tions with normal cerebellar timing function (Solomon
et al., 1994; Elble, 1998; Deuschl et al., 2000; Blangero
et al., 2009; Elble, 2009).
A strong argument in favour of a cerebellar dysfunction
stems from the observed effects of deep brain stimulation
(DBS) of the (sub)thalamic area. Fasano et al. (2010)
described a parallel improvement of tremor and disease-
related gait ataxia in essential tremor with moderate stimu-
lation amplitudes, while a further increase of stimulation
intensity (supra-therapeutic) led to recurrence of gait and
balance problems, despite tremor remaining suppressed.
Similar divergent effects have been observed for tremor
and dysmetria during reach-to-grasp movements (Groppa
et al., 2014). These findings have pointed to two segregated
cerebellar networks being modulated by DBS, a circuit for
the combined control of tremor and disease-related ataxia
and a second circuit inducing ataxia by supra-therapeutic
stimulation (Herzog et al., 2007; Groppa et al., 2014).
Thalamic DBS is now considered a mainstay treatment
for disabling and drug-refractory essential tremor (Putzke
et al., 2004; Pahwa et al., 2006; Fasano et al., 2010). The
procedure has a high responder rate and efficacy (beyond
10 years) for severe tremors and further improved by
moving the stimulation target from the ventro-intermediate
thalamic nucleus to subthalamic fibre pathways (Herzog
et al., 2007; Blomstedt et al., 2009; Baizabal-Carvallo
et al., 2014; Coenen et al., 2014). However, there are
also reports about delayed failure of DBS. A typical clinical
scenario is an improvement of tremor after initial program-
ming, but a subsequent decline in efficacy and the need for
repeated stimulation adjustments. In these cases, progres-
sive motor disability results from a worsening of intention
tremor rather than action or postural tremor and the emer-
gence of additional cerebellar symptoms, such as truncal
ataxia and unsteady gait. Often these patients suffer also
from tremor rebound, an acute exacerbation of tremor and
ataxia beyond the presurgical baseline when turning the
stimulation off. Several explanations have been proposed,
including tolerance development, misdiagnosis, lead mis-
placement and disease progression. The exact proportion
of essential tremor patients with delayed DBS failure is un-
known, but a recent single centre study described a rate of
25% among 28 patients (Favilla et al., 2012). After an
extensive work-up, the authors concluded that only one
of seven patients with DBS failure fulfilled their criteria
for tolerance, whereas the others likely suffered from dis-
ease progression (Favilla et al., 2012). Interestingly, it was
not addressed in this study, whether the severe cerebellar
syndrome could be an adverse effect of prolonged DBS,
given the fact that supra-threshold stimulation provokes
ataxia and that rescue programming attempts often lead
to increasing stimulation intensity.
Following the hypothesis of a stimulation-induced (rather
than disease-related) aetiology, we compared the clinical
outcome of DBS, the disease severity after prolonged stimu-
lation wash-out, the volume of tissue activated (VTA) and
the DBS-related cerebral metabolic changes [18F-fluoro-
deoxyglucose (FDG) PET] in essential tremor patients
with and without DBS failure.
Materials and methods
Subjects and clinical test battery
This study involved 10 patients with pharmacologically in-
tractable essential tremor and bilateral DBS of the (sub)thal-
amic area. Entry criteria were the diagnosis of essential tremor
according to the Tremor Investigation Group and the
Consensus Statement of the Movement Disorder Society
Group (Deuschl et al., 1998) and stable clinical response to
thalamic stimulation for at least 6 months. Exclusion criteria
were any neurological comorbidity (e.g. polyneuropathy).
Patients receiving anti-tremor medication at the time of assess-
ment were also excluded. All patients underwent a preopera-
tive 3 T MRI (T1, T2, T2*, FLAIR, Trio, Siemens Medical
Systems) to rule out morphological anomalies.
We recruited five patients with a secondary DBS failure char-
acterized mainly by chronic-progressive gait ataxia (ETataxia:
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two males; age 75  5 years; disease duration 25  10 years;
time from electrode implantation 23  7 months; aver-
age  standard error of the mean). After an initial benefit on
tremor without any side effect (e.g. gait difficulties), these pa-
tients showed a progressive decline in DBS efficacy (starting
43 months after initial programming) and needed repeated
stimulation adjustments to compensate for the reduced
tremor control. Subsequently, they developed a chronic-pro-
gressive gait ataxia (in the absence of any other DBS-related
adverse event) over a period of at least 4 weeks of chronic
stimulation with unchanged settings.
We also recruited five patients without any gait difficulties or
unsteadiness matched for age, disease duration, time from sur-
gery (ETcontrol: three males; age 54  14 years; disease dur-
ation 31  11 years; time from electrode implantation
25  7 months). The Fahn-Tolosa-Marin Tremor Rating
Scale (TRS) and the Scale of the Assessment and Rating of
Ataxia (SARA) were performed. We recorded only SARA
item 1 to 3 (SARA1-3) as referring to axial signs and not af-
fected by upper limb tremor.
Patients were assessed in the following three conditions: (i)
stimulation on (stim-ON) with the clinically optimized and
chronically used stimulation parameters; (ii) immediately
after deactivating the stimulation (stim-OFFdirect); and (iii)
stimulation off for 72 h (stim-OFF72h). Of note, 72 h was the
minimum time interval after which all subjects reported an
improvement of gait difficulties.
The stimulation parameters were controlled by a physician
independently from this study and provided a sustained im-
provement of tremor without any acute side effect.
Parameters remained unchanged for at least 4 weeks prior to
the study.
Standard protocol approvals, regis-
trations and patient consents
The study was approved by the institutional review board of
the University Hospital of Wuerzburg and by the
Governmental Radiation Protection Authority (Bundesamt
fu¨r Strahlenschutz, Aktenzeichen: Z5-22463/2-2015-010).
Written informed consent was obtained from all subjects.
Surgical procedure
The surgical procedure has been previously described in detail
(Hamel et al., 2002; Herzog et al., 2007). In the present study,
all subjects received quadripolar macroelectrodes (model 3389,
Medtronic Inc.). The stereotactic coordinates of each contact
of the quadripolar macroelectrode related to the midpoint of
the line between anterior and posterior commissure were cal-
culated based on fusion of the preoperative stereotactic and
postoperative MRI. The mean coordinates of the active con-
tacts were x: 12.55  1.63mm, y: 5.15  1.44mm, z:
0.85  1.60mm in ETataxia and x: 12.09  1.62mm, y:
4.55  1.19mm, z: 0.29  2.10mm in ETcontrol.
Volume of tissue activated modelling
Correct lead positioning was verified with SureTuneTM
(Medtronic Eindhoven Design Center, MEDC) by fusing the
preoperative stereotactic MRI with a postoperative CT
performed more than 40 days after electrode implantation.
To visually compare lead location as well as site of stimulation
between ETataxia and ETcontrol, patient images were registered
to a common probabilistic anatomy model of the ventral thal-
amus and subthalamic area. This probabilistic anatomy model
was created by registration and normalization of 50 preopera-
tive T2-weighted MRI volumes. Registration was carried out
with a rigid registration algorithm based on normalized gradi-
ent fields (Ru¨haak et al., 2015), together with a local bounding
box of 30  30  30 mm3 applied around the target area to
define the volume used for registration. VTAs were simulated
and displayed for each lead based on the applied stimulation
parameters (Table 1) (Astrom et al., 2014). A mean VTA was
created for each cohort by aggregating all VTAs of a single
group, and allegorize only voxels that overlapped by 52
VTAs. Volume of mass and centre of mass were calculated
for each mean VTA. In addition, the overlapping volume of
the mean VTAs of the two patient groups was calculated.
Imaging technique and PET data
analysis
PET scans were performed with the PET/CT scanner Biograph
mCT 64 (Siemens Medical Solutions) at the University
Hospital of Wuerzburg.
The patients were scanned on 2 days. On the first day scan-
ning was conducted with the stim-ON, with chronically used
settings. A second scan was performed after 72 h stimulation
off (stim-OFF72h). The PET study was started 30min after the
injection of 208  16.5 MBq of FDG. Before each PET ses-
sion, patients fasted overnight. The studies were performed
with the subjects’ eyes open in a dimly lit room and with
minimal auditory stimulation. The patients’ clinical condition
was monitored by a neurologist (I.U.I.) from the injection of
the radioligand until the end of the scan, and no patient had
overt tremor or ataxia as a potential confounder of cerebral
FDG uptake.
PET was performed in 3D mode for 10min/one bed position
using a 400  400 matrix with an axial resolution of 2mm
full-width at half-maximum and an in-plane resolution of
4.7mm. CT scans for attenuation correction were acquired
using a low-dose protocol. PET data were reconstructed itera-
tively (24 subsets, three iterations, Gaussian filtering) using
HD reconstruction mode.
A group of 10 age- and gender-matched healthy subjects
(HC; five males; age 62  14 years), previously acquired
with the same methods, served as control group.
FDG data preprocessing was performed with statistical para-
metric mapping (SPM 8, Wellcome Department of Cognitive
Neurology, University College, London). Scans were spatially
normalized to a FDG PET template in the standardized
Montreal Neurological Institute (MNI) space (16 iterations,
non-linear transformation and trilinear interpolation) and
then smoothed using a Gaussian kernel at full-width at half-
maximum = 8mm. Paired t-tests were used to assess stimula-
tion effect in voxel-wise maps. Voxel-wise comparisons be-
tween patients with essential tremor and healthy subjects
were performed using the flexible factorial model. The SPM
maps were obtained at a height threshold of P5 0.005, cluster
extent k5 30 voxels. We considered significant peak levels
with Z score53.0.
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SPM findings were also confirmed by a post hoc volume of
interest analysis.We calculated global and regional cerebralmeta-
bolic rates for glucose consumption within the SPM predefined
brain areas. To reduce intersubject variability, the regional meta-
bolic measurements were normalized by global values.
Statistical analysis
Statistical analyses were performed with the JMP statistical
package, (version 12, SAS Institute, Inc., Cary, NC, USA).
Gender difference between groups was analysed using
Pearson’s chi-squared test. Other differences between groups
were analysed by means of Mann-Whitney U-test. The thresh-
old level of statistical significance was set at P50.05.
Results
Clinical evaluation
Evaluation of the TRS demonstrated a significant tremor
reduction (470%) during stim-ON in all patients.
ETcontrol showed greater benefit from stimulation (TRS
scores for ETcontrol 2.0  2.3 and ETataxia: 7.8  4.2,
P = 0.014). The mean TRS score in stim-OFF72h was simi-
lar between the two groups of patients (ETataxia: 17.2  5.9
and ETcontrol: 14.2  2.3, P = 0.34). Age, disease duration
and time after implantation did not influence tremor
improvement.
As expected, the SARA1-3 score in stim-ON was signifi-
cantly higher for ETataxia than ETcontrol (6.2  0.6 versus
0.2  0.6, P = 0.001).
Directly after switching off the stimulation (stim-
OFFdirect), we observed a severe rebound of ataxia in
both groups, sometimes leaving the patient bedridden,
which gradually disappeared in the follow-up period.
After 72 h of deactivated stimulation (stim-OFF72h), all
ETataxia subjects reported a significant improvement in
gait difficulties and unsteadiness, which was mirrored by
a lower SARA1-3 score (Fig. 1).
Volume of tissue activated by high-
frequency stimulation
Mean VTA volumes of the ETataxia and ETcontrol group
were 86 mm3 and 68 mm3, respectively, with an overlap
of the two volumes by 37.5 mm3. Mean VTA of ETataxia
was located inferior and posterior in relation to mean VTA
of ETcontrol centre of mass mean VTA reflecting this finding
(ETataxia: x: 11.6mm; y: 4.7mm; z: 1.0mm; ETcontrol: x:
13.1mm; y: 4.2mm, z: 2.2mm) (Fig. 2A).
Brain metabolic changes induced by
brain stimulation
Pairwise correlations of stimulation-induced changes are
presented in Table 2 and Fig. 3. The most prominent
effect of stimulation was a distinctive increment of FDG
uptake in the cerebellar nodule of ETataxia patients but
not in ETcontrols. DBS also had a marked impact on thal-
amic metabolic activity of both essential tremor cohorts, as
seen by the increased FDG uptake in the left and right
thalamic ventral posterior nucleus (which corresponds to
the ventral intermedius nucleus) (Nazzaro et al., 2013).
Similar results were found when evaluating glucose con-
sumption of predefined volume of interest. Of relevance,
no difference was found when comparing cerebellar glucose
consumption of all essential tremor (in stim-OFF72h) to
healthy controls, which was also true when considering
only the volume of interest placed on the cerebellar nodule.
Table 1 Chronic stimulation parameters
Stimulation parameters
Subjects IPG Right
contact
Right
(mA)
Right
(ks)
Right
(Hz)
Left
contact
Left
(mA)
Left
(ks)
Left
(Hz)
ETataxia_01 Medtronic Activa PC 1 + 0 1.8 60 180 9 + 8 2.3 60 180
ETataxia_02 Medtronic Activa PC G + 8 2.0 60 125 3 + 0 3.0 60 125
interleaved interleaved interleaved interleaved
G + 9 1.5 3 + 1 3.0
ETataxia_03 Medtronic Activa PC 10 + 98 3.3 60 180 2 + 10 3.9 60 180
ETataxia_04 Medtronic Activa PC G + 1 2.1 60 180 G + 8 1.7 60 180
ETataxia_05 St. Jude Brio 3 + 4 3.5 50 160 3 + 2 3.0 50 160
Mean 2.49 58 165 2.78 58 165
ETcontrol_01 Medtronic Activa PC G + 2 3.0 60 180 G + 8 1.7 60 180
ETcontrol_02 Medtronic Activa PC G + 8 0.9 60 140 G + 0 1.2 60 140
ETcontrol_03 Medtronic Activa PC 10 + 9 0.9 90 130 G + 1 2.5 60 130
ETcontrol_04 Medtronic Activa PC G + 1 2.3 90 130 G + 9 2.0 60 130
ETcontrol_05 Medtronic Activa PC G + 10 2.0 60 170 G + 1 2.6 60 170
Mean 1.82 72 150 2.0 60 150
IPG = implantable pulse generator.
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Discussion
In this study, we forward evidence that chronic-progressive
gait ataxia in subjects with essential tremor is reversible
after a prolonged DBS washout and emerges from a stimu-
lation-induced vestibulocerebellar network dysfunction.
Two main observations support this view: (i) a gradual
improvement of gait ataxia after pausing stimulation for
72 h; and (ii) increased neuronal metabolic activity in the
cerebellar nodule of patients with chronic-progressive gait
ataxia as compared to essential tremor without. We further
propose that cerebellar dysfunction in subjects with ETataxia
is a remote effect of inadvertent antidromic stimulation of
vestibulocerebellar-thalamic afferents within the subthala-
mic target area of DBS.
Several studies have reported cerebellar ataxia as a clin-
ical feature of advanced essential tremor (Fasano et al.,
2010). However, it is worth noting that the chronic-pro-
gressive gait ataxia described here clearly differs from the
disease-related ataxia, which is milder in its presentation
and is typically ameliorated by thalamic-stimulation, irre-
spective of the affected body site and independently of co-
existing tremor. Of note, a sufficiently long washout of
DBS is required to overcome the initial tremor and ataxia
rebound and re-establish a disease baseline, which may ex-
plain the partially conflicting observations in previous stu-
dies. A previous study reported a worsening of untreated
tremor 1 year after DBS implantation, but thalamic stimu-
lation was deactivated for 30min only. As shown by our
results (Fig. 1), clinical changes after such a small time
interval possibly reflect just the pausing of stimulation per
se rather than the progression of the disease.
It is worth noting that chronic-progressive gait ataxia
also differs from acute upper limb ataxia induced by
(supra)therapeutic stimulation (Groppa et al., 2014). The
delayed onset of gait ataxia with chronic DBS suggests a
maladaptive component probably involving a different cer-
ebello-thalamo-cortical fibre system. Alternatively, intracer-
ebellar compensatory mechanisms may be taken into
account. Indeed, the lateral hemispheres of the cerebellum
can greatly compensate for the loss of function of the
vermis and the flocculonodular lobe, as seen for example
in subjects with Joubert syndrome (Romani et al., 2013).
Several physiological studies in monkey and humans have
provided evidence that the cerebello-thalamo-cortical circuit
is essential for gait and balance (Diener et al., 1984; Ito¯,
1984; Hallett and Massaquoi, 1993; Armstrong and
Marple-Horvat, 1996; Cooper et al., 2000; Ilg et al.,
2007; Blangero et al., 2009). Real locomotion FDG PET
studies have also confirmed a prominent activation in the
vermal and paravermal cerebellum, with extensions into the
superior cerebellar peduncle bilaterally (Ishii, 1995; la
Fougere et al., 2010).
Three distinguished cerebello-thalamo-cortical subcircuits
might be particularly relevant in the pathophysiology of
thalamic stimulation-induced effects in essential tremor
(Fig. 4).
First, the dentato-thalamic tract is the main output of the
lateral cerebellum and projects to the motor cortex via the
ventrolateral thalamus. The dentato-thalamic system is
mainly involved in the control of voluntary movements of
the extremities, such as single-joint and multi-joint goal-
directed movements (Schwartz et al., 1987; Marple-
Horvat et al., 1998; Marple-Horvat and Criado, 1999;
Cooper et al., 2000). These fibres are supposed to mediate
the tremor and ataxia suppressing effect of thalamic-stimu-
lation in essential tremor (Groppa et al., 2014).
Second, the cerebello-rubrospinal system is involved in
the sensory-to-motor transformation required for cerebellar
control of goal-directed limbs movements. Stimulation
(supratherapeutic) of these fibres was shown to induce the
reappearance of ataxia, in particular the spatial variability
during the deceleration phase of reach-to-grasp movements,
Figure 1 Clinical outcomes. (A) Fahn-Tolosa-Marin Tremor Rating Scale and (B) Assessment and Rating of Ataxia (mean  SD) item 1–3 under
chronic thalamic stimulation (stim-ON), directly after deactivating DBS (stim-OFFdirect) and after stimulation off for 72 h (stim-OFF72h). Tremor
greatly ameliorated (470%) in all patients after thalamic stimulation. We observed a severe rebound of tremor and ataxia directly after switching off
the stimulation (stim-OFFdirect), which disappeared in the follow-up period (stim-OFF72h). ETcontrol = dotted line; ETataxia = continuous line.
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while maintaining near complete suppression of tremor
(Groppa et al., 2014).
Third, the fastigio-bulbar tract projects from the cerebel-
lar vermis and nodule to the motor thalamus, spinal cord
and vestibular system. In particular, its ascendant uncinate
tract projects to the ventrolateral/intralaminar thalamic
nuclei (Paxinos and Mai, 2004). This tract is particularly
important for axial coordination during movements and its
failure results in severe gait ataxia (Sprague and Chambers,
1953; Imperato et al., 1984).
These cerebello-thalamic fibres run parallel with a clear
functional-anatomical organization, the appendicular move-
ments control being situated in a lateral bundle and the
axial one more medially. In the (sub-)thalamic area how-
ever, these fibres run in close vicinity and effective DBS
targeting the lateral fibres may inadvertently co-stimulate
medial cerebello-thalamic tracts (Groppa et al., 2014).
Indeed, our study showed that the VTA of ETataxia is
located more posteromedial and caudally in the (sub)thal-
amic area when compared to ETcontrol.
VTA modelling is a novel tool that computes the region
in which certain stimulation settings may induce action po-
tentials in model neurons (Butson et al., 2011). Current
VTA modelling depends on stimulation parameters, tissue
impedance and tissue anisotropy (McNeal, 1976; Butson
et al., 2006). A possible limitation of this model is the de-
pendency on a priori assumptions about the membrane
properties of the stimulated axons. However, it was re-
cently shown that VTA mirrored such neuronal proprieties
as clinically defined (i.e. chronaxies) (Reich et al., 2015).
Finally, VTA assumes that the primary effect of DBS is to
activate myelinated axons, which was proved by several
studies (Holsheimer et al., 2000; Paxinos and Mai, 2004;
Groppa et al., 2014).
Current spreading into the ascending limb of the uncinate
tract may directly influence the activity of cerebellar nodule
as suggested by an increased FDG uptake in this area.
Indeed, it was shown that DBS stimulation could affect
functionally connected brain areas remote from the stimu-
lation site (Hilker et al., 2008). Accordingly, we advance
the hypothesis that the hypermetabolism in the cerebellar
Figure 2 Reconstruction of the mean volume of tissue
activated for ETcontrol and ETataxia on a standard MRI. (A)
Mean VTAs (voxels covered by 52 VTA in the co-registration of
each subject) in 3D and axial plane on T2-weighted MRI Space.
ETcontrol = 70 mm
3 (light blue volume) and ETataxia = 90 mm
3 (red
volume). In comparison to the mean VTA of ETcontrol, the mean VTA
of ETataxia is closer to the posteromedial border of the subthalamic
nucleus (light brown) and the risk of ataxic gait increases with
greater proximity to the red nucleus (pink). (B) Co-registration of
volume of tissue activation (VTA) modelling and statistical para-
metric mapping. Mean VTA of ETataxia (red) was related to increased
metabolic rates for glucose consumption in the cerebellar nodule
and electrode surrounding area (light grey) possibly due to anti-
dromic activation of cerebello-thalamic fibres caused by current
spreading into the ascending limb of the uncinate tract. Subthalamic
nucleus (light brown); red nucleus (pink).
Table 2 Brain areas (coordinates and regions in Talairach space) with significantly increased glucose consumption
P k Region Coordinates (mm) Z-
score
x y z
ETataxia
Stim-ON versus stim-OFF72h
0.000 37 Thalamus, VP (left) 14 18 0 3.84
0.000 31 Cerebellum, nodule 4 50 34 3.55
0.001 66 Thalamus, VP (right) 22 18 6 3.12
ETcontrol
Stim-ON versus stim-OFF72h
0.000 43 Thalamus, VP (right) 18 20 2 3.75
Nucleus ventralis posterior (VP) corresponds to the ventral intermedius nucleus in the stereotactic atlas of Schaltenbrand and Wahren (Nazzaro et al., 2013).
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nodule shown in ETataxia is due to antidromic activation of
cerebello-thalamic fibres caused by the stimulation electric
field. A cerebellar compensatory activity due to tremor
seems unlikely as we tested the patients in resting condi-
tion, closely monitoring the complete absence of upper limb
movements that could affect FDG uptake. Moreover, an
antidromic activation of dentate-thalamic fibres—the pre-
sumed target of effective thalamic DBS—can also be
excluded, as it would induce metabolic changes of the lat-
eral cerebellum. Here, we also confirm a previous study
reporting no abnormalities of glucose metabolism in the
cerebellum of non-DBS treated essential tremor patients.
These findings further support a stimulation-induced hyper-
metabolism rather than a disease-related cerebellar path-
ology (Hallett and Dubinsky, 1993; Song et al., 2015).
We also confirmed previous reports of an enhanced neur-
onal activity in the area surrounding the active electrodes
(i.e. thalamic area) of all essential tremor subjects (Hilker
et al., 2008; Martin-Blanco et al., 2015) and no other brain
region.
FDG is a marker of hexokinase activity that regulates the
regional cerebral glucose metabolic rate. Quantification of
the regional glucose accumulation can be performed by
PET and correlates with regional synaptic activity (Otte
and Halsband, 2006). In particular, sequential FDG PET
is an established method to identify metabolic changes in
subcortical structures with comparable size (Hilker et al.,
2008; Le Jeune et al., 2009; Wang et al., 2010). Despite
being small, the regions of interest (e.g. cerebellar nodule)
more than double the resolution of our PET/CT. Partial
volume effect is therefore unlikely to occur and even if
present, it would underestimate the activity of small struc-
tures (Heiss et al., 2004).
A possible limitation of this study is the small sample
size. However, the hypermetabolism in the cerebellar
nodule was consistently detected in all ETataxia subjects
and the number of included patients is comparable to pre-
vious studies addressing a similar topic (Groppa et al.,
2014).
In conclusion, our study suggests that chronic-progressive
gait ataxia in essential tremor is a reversible cerebellar symp-
tom probably induced by inadvertent stimulation of the
Figure 3 SPM analysis of ETataxia in stim-ON versus stim-OFF72h. Chronic stimulation compared to a 72 h stimulation washout is
associated with significant increases of FDG in the cerebellar nodule and both thalamic ventral intermedius nucleus in the ETataxia group.
Figure 4 Modified diagram of parallel channels in the
cerebello-thalamic-cortical projection from Paxinos and
Mai (2004). This model shows the subdivision of the cerebellar
territory of the motor thalamus (ventral intermedius nucleus) into
ventrolateral (VImL) and dorsomedial subparts (VImM). The overlap
of vestibular and spino-thalamic projections in the VImL is indicated.
It also shows the connections of the cerebellar nuclei with the
thalamus. (I) The dentato-thalamic tract, arising from the lateral
cerebellar zones, is the presumed target of effective thalamic DBS.
(II) The rubro-olive-cerebellar tract, which originates from olivary
nucleus to be distributed to the cerebellar hemisphere via raphe
nucleus. It might be causative of the (supratherapeutic) stimulation-
induced limb ataxia. (III) The ascendant uncinate tract (fastigulus
bulbar fibres) that arises from the medial cerebellar structures and it
is probably associated with chronic-progressive gait ataxia. The
stimulation lead shows the ‘classical’ surgical target: the second
lowest electrode in the middle of the VIim and the lowest electrode
on the border to the white matter (posterior zona incerta).
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ascending limb of the uncinate tract, which in turn affects
the cerebellar nodule functioning (Fig. 2B). Following this
hypothesis, avoiding a too caudal and ventral placement of
standard DBS electrodes or directing current away from this
region with novel DBS systems capable of horizontal current
steering might prevent this chronic side effect. As estimated
from the VTA of patients without ataxia, a relatively safe
target to be further refined by intraoperative stimulation re-
sults could be the lateral part of the posterior subthalamic
area, which has been proposed more than 30 years ago
(Velasco et al., 1972) as the optimal target for severe tre-
mors. For direct anatomical targeting on axial T2-weighted
MRI the posterior and medial border of the subthalamic
nucleus at the level of the largest diameter of the red nucleus
may be used as a reference (Blomstedt et al., 2009) (Fig. 5).
As previously suggested, a shorter pulse duration of 560ms
could constitute an alternative approach of selectively stimu-
lating dentato-thalamic fibres close to the DBS lead based on
divergent chronaxies of different subthalamic fibre tracts
(Reich et al., 2015).
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